As gene therapy sales sputter, one biotech aims to defy the odds
Written by
BioPharma Dive
Published
0
comments
0
min
With a strong launch underway for a bladder cancer gene therapy, Ferring Pharmaceuticals is finding the kind of commercial success that’s eluded many of its peers.